NADH availability limits asymmetric biocatalytic epoxidation in a growing recombinant Escherichia coli strain.
about
Flavoprotein monooxygenases for oxidative biocatalysis: recombinant expression in microbial hosts and applicationsGenome-scale modeling using flux ratio constraints to enable metabolic engineering of clostridial metabolism in silico.A stepwise approach for the reproducible optimization of PAMO expression in Escherichia coli for whole-cell biocatalysis.Determining the extremes of the cellular NAD(H) level by using an Escherichia coli NAD(+)-auxotrophic mutantThe CreC Regulator of Escherichia coli, a New Target for Metabolic Manipulations.Engineering NAD+ availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production.A review-biosynthesis of optically pure ethyl (S)-4-chloro-3-hydroxybutanoate ester: recent advances and future perspectives.Guidelines for development and implementation of biocatalytic P450 processes.Whole cell biotransformation for reductive amination reactions.Proline availability regulates proline-4-hydroxylase synthesis and substrate uptake in proline-hydroxylating recombinant Escherichia coli.Variability in subpopulation formation propagates into biocatalytic variability of engineered Pseudomonas putida strains.Anaerobic obligatory xylitol production in Escherichia coli strains devoid of native fermentation pathways.Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.Metabolic response of Pseudomonas putida during redox biocatalysis in the presence of a second octanol phase.Decoupling production from growth by magnesium sulfate limitation boosts de novo limonene production.Maximization of cell viability rather than biocatalyst activity improves whole-cell ω-oxyfunctionalization performance.Synthesis of chiral 2-alkanols from n-alkanes by a P. putida whole-cell biocatalyst.Pyridine nucleotide transhydrogenases enable redox balance of Pseudomonas putida during biodegradation of aromatic compounds.The dynamic influence of cells on the formation of stable emulsions in organic-aqueous biotransformations.Engineering class I cytochrome P450 by gene fusion with NADPH-dependent reductase and S. avermitilis host development for daidzein biotransformation.Whole-cell hydroxylation of n-octane by Escherichia coli strains expressing the CYP153A6 operon.Multistep Enzymatic Synthesis of Long-Chain α,ω-Dicarboxylic and ω-Hydroxycarboxylic Acids from Renewable Fatty Acids and Plant Oils
P2860
Q21131111-994B35FF-7C98-4BDB-BB54-4D798878E022Q34268420-BC674E4C-2AD5-4798-A4C3-541AC58CF657Q34312636-1266CCB8-16BD-4110-B054-AA982E1450E2Q35191689-EC40CCAD-8F2F-47A0-8888-EBB347473D43Q36434146-EF592BA9-7A96-4461-B62C-E4A440418AA1Q37319129-5CB62149-D280-4153-9FBE-52DE8073D045Q37801307-BC5504D9-F183-4F8B-8688-4BA10B164275Q38344548-571C90E0-5058-4B45-986E-BCE0BAE46F38Q39174151-907AC2A8-DDB3-4D5A-92A3-DC0821F8426FQ39762292-3A0DD58A-33DF-4DE4-922C-B1954F4058BEQ41548175-1BFB0470-FC58-4DDA-A41C-F42469BA6F7DQ42042348-88CACA39-CB9A-4162-AD56-60455CCEFAA7Q46216816-4731BBA6-D825-4B2F-A168-C5E42C552904Q46357643-98F809D3-6CE5-4132-ACCD-5DA2D2241128Q47627138-8C022160-1A4E-4481-8E16-AF6E5E7E64DCQ51093711-13AFDFC1-D0C2-4536-909D-2725DDC526DCQ51515912-CE67EC7C-1789-4654-8539-9892BC77C928Q51678908-0A4CFA15-64A0-4461-8A98-8D27E092B023Q53251678-ADECB430-38F5-4EAB-B117-BB68F22C3A32Q53569237-A5BB8EC9-2C2E-42C7-AB8F-57B2FE24A0DFQ54340608-84EB1030-27A6-46F4-9EDA-EC94D9E9170DQ57189226-80AC1E20-AD8D-4BA3-A9E0-96FF02DDF641
P2860
NADH availability limits asymmetric biocatalytic epoxidation in a growing recombinant Escherichia coli strain.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
NADH availability limits asymm ...... inant Escherichia coli strain.
@en
NADH availability limits asymm ...... inant Escherichia coli strain.
@nl
type
label
NADH availability limits asymm ...... inant Escherichia coli strain.
@en
NADH availability limits asymm ...... inant Escherichia coli strain.
@nl
prefLabel
NADH availability limits asymm ...... inant Escherichia coli strain.
@en
NADH availability limits asymm ...... inant Escherichia coli strain.
@nl
P2860
P356
P1476
NADH availability limits asymm ...... binant Escherichia coli strain
@en
P2093
Jin-Byung Park
Lars M Blank
P2860
P304
P356
10.1128/AEM.02234-07
P407
P577
2008-01-11T00:00:00Z